The Scan

A Senate committee voted unanimously yesterday to approve Kelvin Droegemeier as science advisor, Nature News reports.

CNBC reports that genetic testing company 23andMe is looking into offering a premium sequencing-based service.

Synthetic Treatment

Researchers from Synlogic are testing a synthetic biology-based treatment for phenylketonuria, according to the New York Times.

This Week in Nature

In Nature this week: new susceptibility loci for diverticular disease, and more.

Good-Bye to Theranos

Blood-testing firm Theranos is to shutter, the Wall Street Journal reports.

The Guardian reports that senior management at the Wellcome Sanger Institute is under investigation after allegations of bullying and discrimination.

Early Glimpse

The Associated Press reports on early, potentially promising results from a gene-editing trial.

In Genome Biology this week: genome sequencing study of a wild cherry tree, transcriptomic analysis of a planarian model organism, and more.

The Path It'll Take

An Institute of Cancer Research-led team has developed a machine-learning tool to predict how tumors may evolve, according to the Telegraph.

Call for More

Japan's science ministry wants a budget increase of about 20 percent, Science reports.


US companies have begun recruiting for a CRISPR-based gene-editing trial to treat β-thalassemia, Stat News reports.

This Week in PNAS

In PNAS this week: DNA vaccine-based approach for Duchenne muscular dystrophy tested in mice, antimicrobial found in bear saliva, and more.

But, Why?

Commercial genetic tests are bringing together biological children of fertility doctor who slipped patients his own sperm.

Perchance, Two Genes

Dreams just might stem from two genes, according to a new mouse study.

Recognizing Rare

The Boston Globe describes facial recognition software designed to help diagnose rare genetic conditions.

This Week in Science

The opium poppy genome, gene editing in Duchenne muscular dystrophy, and complex Ewing sarcoma rearrangements.

The Genetic Detective

The New York Times profiles a genetic genealogist who helped nab the Golden State Killer.

Not Nebulous

In Medium, George Church talks Nebula Genomics and the potential benefits of personal genome sequencing.

Trees for the Forest

Nature News looks at strategies for restoring lost woodlands.

This Week in Nature

Cave bear persistence, preservative marks, and more.

There Must Be More?

The search is on for more individuals with a rare genetic condition, after a diagnosis made through the National Institute's of Health's Undiagnosed Diseases Network.

Another Dimension

New research offers a 3D view of the human genome using a sequencing-based approach.

Places, Not Races

An anthropologist expresses concern about the way ancestry results are reported by commercial genetic testing companies.

INFERNO software for interpreting non-coding variants from association studies, a new Streptococcus pneumoniae genome annotation, and S. pneumoniae transcriptomes.

The study published in Nature Neuroscience says the cell is present in people but not in mice, ScienceInsider reports.


The National Science Foundation is adding questions about sexual orientation and gender identity to its Survey of Earned Doctorates, according to Science Careers.

Nature asked scientists whether they were satisfied with their careers to find that most were, with some variation.

Gene editing is expected to give rise to new job opportunities, according to BBC Capital.

A new analysis finds that better grant-writing skills may help early-career researchers stay funded and stay in academia.